Dr. Karim was with the Johnson & Johnson organization (JNJ) for over 20 years holding various leadership positions, primarily within Pharmaceutical R&D. He has a strong track record in clinical research and regulatory submissions, resulting in several global innovative drug approvals (NDA/sNDA/BLA).In his most recent position within JNJ, Dr. Karim was Director of Global Medical Safety in Janssen Pharmaceuticals and worked as an internal statistical consultant within Global Medical Safety. His responsibilities involved working closely with pharmacovigilance colleagues, developing and evaluating new analytical tools for drug safety using novel and computer-assisted methodologies for analyzing safety databases (such as, global regulatory safety database, insurance claims database, EMR/EHR, etc.). His broad-based experience also includes the Protocol Review Committee, Clinical Data Warehousing and Data Mining initiatives, Risk Assessment, Licensing and Due Diligence activities.Currently, Dr. Karim is involved (as investor and advisor) in Green Technology and Healthcare sectors. He has been a cofounder of a Renewable Energy startup company (now a public company), and has Invested in 100+ startup companies, 8 of them have gone public. He is also involved in voluntary activities related to Sustainability and Resilience.Dr. Karim’s specialties are Biostatistics/Epidemiology, Pharmacovigilance, Health Information Technology, Green Technology, Sustainability, and Resilience. He has written numerous peer-reviewed scientific and conference papers. A list of these articles is available at Google Scholar (https://scholar.google.com/citations?user=h9E-wUEAAAAJ&hl=en).